Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.37 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | ARF6 | P62330 | 1/20 | 0.35 |
| ▸ | CDC7 | O00311 | 2/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | XDH | P47989 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12293879 | 0.95 | ABCB1 (0.42) | ABCB1ADORA3ALDH1A1HSD17B10CDC7 | |
| SCHEMBL64690 | 0.95 | ABCB1 (0.42) | ABCB1ADORA3ALDH1A1HSD17B10CDC7 | |
| SCHEMBL954434 | 0.94 | ABCB1 (0.41) | ABCB1ADORA3ALDH1A1HSD17B10CDC7 | |
| SCHEMBL16154083 | 0.93 | ADORA3 (0.38) | ADORA3PTGDR2ALDH1A1MEN1KMT2A | |
| SCHEMBL2680751 | 0.93 | ABCB1 (0.40) | ABCB1ADORA3ALDH1A1HSD17B10CDC7 | |
| SCHEMBL24329824 | 0.90 | ADORA3 (0.39) | ADORA3ALDH1A1MEN1KMT2ACYP1A2 | |
| SCHEMBL20841761 | 0.90 | ABCB1 (0.39) | ABCB1ADORA3ALDH1A1MEN1KMT2A | |
| SCHEMBL20841749 | 0.90 | ABCB1 (0.39) | ABCB1ADORA3PTGDR2ALDH1A1CDC7 | |
| SCHEMBL10196941 | 0.90 | ABCB1 (0.39) | ABCB1ADORA3ALDH1A1CDC7ADORA1 | |
| SCHEMBL10196888 | 0.90 | ABCB1 (0.39) | ABCB1ADORA3ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12130292-B2 | Full length kinase activity-conformation reporter | KINCON BIOLABS GMBH (AT) | 2024-10-29 | — | — | US | disclosed |
| US-20240239803-A1 | SYNTHESIS OF COELENTERAZINE | INTERNATIONAL PAPER COMPANY | 2024-07-18 | — | — | US | disclosed |
| US-20240239803-A1 | SYNTHESIS OF COELENTERAZINE | INTERNATIONAL PAPER COMPANY | 2024-07-18 | — | — | US | disclosed |
| US-20230366023-A1 | METHODS AND COMPOSITIONS FOR BIOLUMINESCENCE-BASED SEQUENCING | BGI SHENZHEN GROUP HOLDINGS CO. LIMITED (CN) | 2023-11-16 | — | — | US | disclosed |
| US-20230366023-A1 | METHODS AND COMPOSITIONS FOR BIOLUMINESCENCE-BASED SEQUENCING | BGI SHENZHEN GROUP HOLDINGS CO. LIMITED (CN) | 2023-11-16 | — | — | US | disclosed |
| EP-3519830-B1 | FULL LENGTH KINASE ACTIVITY-CONFORMATION REPORTER | KINCON BIOLABS GMBH (AT) | 2023-07-19 | — | — | EP | disclosed |
| US-11691976-B2 | Coelenterazine analogues | PROMEGA CORPORATION (US) | 2023-07-04 | — | — | US | disclosed |
| US-11691976-B2 | Coelenterazine analogues | PROMEGA CORPORATION (US) | 2023-07-04 | — | — | US | disclosed |
| WO-2022170177-A1 | FUSION PROTEINS AND METHODS OF USING THE SAME FOR THE DETECTION OF NEUTRALIZING ANTIBODIES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2022-08-11 | — | — | WO | disclosed |
| US-20220137060-A1 | FULL LENGTH KINASE ACTIVITY-CONFORMATION REPORTER | KINCON BIOLABS GMBH (AT) | 2022-05-05 | — | — | US | disclosed |
| EP-3519830-A1 | FULL LENGTH KINASE ACTIVITY-CONFORMATION REPORTER | Universität Innsbruck (AT) | 2019-08-07 | — | — | EP | disclosed |
| US-20190203187-A1 | CHEMILUMINESCENT WETNESS INDICATOR FOR ABSORBENT PRODUCTS | INTERNATIONAL PAPER COMPANY (US) | 2019-07-04 | — | — | US | disclosed |
| WO-2018060415-A1 | FULL LENGTH KINASE ACTIVITY-CONFORMATION REPORTER | UNIVERSITÄT INNSBRUCK (AT) | 2018-04-05 | — | — | WO | disclosed |
| WO-2017182437-A1 | QUANTIFICATION OF AN INTERACTION BETWEEN A RAS PROTEIN AND A RAF PROTEIN | UNIVERSITÄT INNSBRUCK (AT) | 2017-10-26 | — | — | WO | disclosed |
| US-20160281129-A1 | LUMINESCENT SUBSTRATE FOR USE IN ARTIFICIAL BIOLUMINESCENT ENZYME | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20160281129-A1 | LUMINESCENT SUBSTRATE FOR USE IN ARTIFICIAL BIOLUMINESCENT ENZYME | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20100105090-A1 | SECRETED LUCIFERASE MLUC7 AND USE THEREOF | BAYER HEALTHCARE AG (DE) | 2010-04-29 | — | — | US | disclosed |
| US-20100105090-A1 | SECRETED LUCIFERASE MLUC7 AND USE THEREOF | BAYER HEALTHCARE AG (DE) | 2010-04-29 | — | — | US | disclosed |
| US-7396655-B2 | Method for enhancing activity of luciferase with fluorescence activity | CHISSO CORPORATION (JP) | 2008-07-08 | — | — | US | disclosed |
| US-7396655-B2 | Method for enhancing activity of luciferase with fluorescence activity | CHISSO CORPORATION (JP) | 2008-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11691976-B2 | Coelenterazine analogues | GLB1, SI, TCF7L2 | ABCB1 1116/4885ADORA3 3089/4885PTGDR2 3614/4885 |
| US-20160281129-A1 | LUMINESCENT SUBSTRATE FOR USE IN ARTIFICIAL BIOLUMINESCENT ENZYME | GALC, GUSB, GLB1 | ABCB1 3205/4885ADORA3 1043/4885PTGDR2 4302/4885 |
| US-20100105090-A1 | SECRETED LUCIFERASE MLUC7 AND USE THEREOF | LUC7L2, MRPL37, TCF7 | ABCB1 3223/4885ADORA3 3953/4885PTGDR2 4619/4885 |
| US-20240239803-A1 | SYNTHESIS OF COELENTERAZINE | ACHE, UROD, DDT | ABCB1 1652/4885ADORA3 1581/4885PTGDR2 1550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.